Applicant, as named in the Orange Book

Ocuvex Therap

Next listed expiry: Omlonti on 16 Jul 2039. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Omlonti NDA 215092 omidenepag isopropyl	omidenepag isopropyl	16 Jul 2039 patent, carve-out possible	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.